MENU
The Journal of UOEH (the Journal of University of Occupational and Environmental Health, Japan) is an open access, peer-reviewed journal published quarterly by the UOEH Association of Health Sciences. Submissions in English are considered from authors around the world on all areas of occupational and environmental health. The submission of manuscripts on related topics in other fields of medicine or humanities are also considered. Article types include Original Research Papers, Review Articles, Reports, Case Reports, Technical Notes, and others.
The Journal of UOEH publishes original and rigorous work that is relevant to a global audience of researchers, clinicians and others interested in occupational and environmental health. Authors benefit from rapid, full peer review. Articles are published in issues four times year and are available by open access on the journalfs website (https://www.uoeh-u.ac.jp/kouza/journal/intro_e.html).
The journal welcomes the types of manuscripts described below, all of which are subject to peer review. Except for invited manuscripts, each article should not exceed 10 journal-typeset pages, including tables and figures (see the eManuscript Preparationf section for more information).
Full and comprehensive reports describing original research, presented in the standard format of Abstract (not exceeding 250 words), Introduction, Materials and Methods, Results, Discussion, and References. The main text (excluding references, tables, and figure legends) should not exceed 5,000 words.
Articles presenting novel or unique overviews of recent or important developments in the field. Reviews must be insightful and must address the question(s) of interest using appropriate and fully presented evidence; exhaustive general summaries will not be published. Reviews are generally 5,000-10,000 words long and can explore several aspects of importance in a broader subject area. Reviews are occasionally commissioned by the Editor-in-Chief, and the journal welcomes proposals from interested authors.
Results of original research of particular importance or observations of immediate impact that potentially reveal new aspects of the field. Reports are approximately 4,000 words long. Brief reports (around 1,500 words long) providing new information or data on controversies of broad interest or long-standing questions are also considered and should follow the format for Original Research Papers, but contain no more than 5 references.
Case Reports should provide novel or outstanding clinical-oriented information of a particular case or case series, including a patient management, diagnostic approach, and treatment. They should be written concisely (generally within 2,000 words) and be fully supported by the underlying data.
Technical Notes should describe new or updated tools or methods of particular importance. They are generally 2,000 words long and should follow the format for Original Research Papers, but the headings in the main text can be modified accordingly.
Other types of manuscripts, such as Letters to the Editor, may be eligible for publication after peer review, but authors must contact the Editorial Office before submission.
The Journal of UOEH upholds the highest standards in scholarly publishing.
Before submitting a manuscript to the journal, authors must ensure that they have read and complied with the journalfs policies. The journal reserves the right to reject without review or to retract any manuscript that the Editor believes may not comply with these policies.
The responsibilities of the journalfs authors, editors, reviewers, and publisher regarding research and publication ethics are described in full below.
Submission to the journal implies that the manuscript has not been previously published (in part or in whole, in any language), is not in press, and is not under consideration for publication elsewhere.
Authors must inform the editors if any related manuscripts are under consideration, in press or published elsewhere.
If authors choose to submit their manuscript elsewhere before a final decision has been made on its suitability for publication in the journal, they must first withdraw it from the journal.
The journal welcomes manuscript submissions from authors based anywhere in the world.
Submission of a manuscript to the journal implies that all authors have approved it, warrant it is factual, have agreed to its submission, and have the right to publish it.
Submission to the journal implies that the manuscript is original work. The journal uses iThenticate plagiarism software to screen manuscripts for unoriginal content. By submitting a manuscript to the journal, authors agree to this screening. Any manuscript with an unacceptable level of unoriginal material will be rejected or retracted at the editorsf discretion.
Submission to the journal implies that all authors have seen and approved the author list. Changes to the author list after manuscript submission - such as the insertion or removal of author names, or a rearrangement of author order - must be approved by all authors and the editor.
Authors are encouraged to consider the International Committee of Medical Journal Editors (ICMJE) Recommendations on eDefining the Role of Authors and Contributorsf. The ICMJE recommends that authorship is based on four criteria: making a substantial contribution to the conception or design of the work, or the acquisition, analysis or interpretation of data for the work; drafting the manuscript or revising it critically for important intellectual content; approving the final version of the manuscript for publication; and agreeing to be held accountable for all aspects of the work. Any contributor who has met all four criteria should be an author on the manuscript. Contributors who do not meet all four criteria should not be authors of the manuscript but may be included in the Acknowledgments section instead.
Authors are required to include a statement that specifies the contribution of each author as per the eAuthor contribution statementf section in this document.
Given that artificial intelligence (AI) tools such as large language models (LLMs) and various openly available services cannot meet the requirements above, they cannot be listed as authors.
Authors must not falsify or fabricate data. Authors may digitally manipulate or process images, but only if the adjustments are kept to a minimum, are applied to the entire image, meet community standards, and are clearly described in the manuscript. All images in a manuscript must accurately reflect the original data on which they are based. Authors must not move, remove, add or enhance individual parts of an image. The editors reserve the right to request original, unprocessed images from the authors. Failure to provide requested images may result in a manuscript being rejected or retracted.
If a manuscript includes material that is not under the authorsf own copyright, the authors must obtain permission from the copyright holder(s) to reproduce it. If a manuscript includes previously published material, the authors must obtain permission from the copyright owners and the publisher of the original work to reproduce it. The authors must cite the original work in their manuscript.
Copies of all reproduction permissions must be included with the manuscript when it is first submitted.
Authors must provide a Data Availability Statement to the end of their article, before the reference. The statement examples below are derived from Hrynaszkiewicz et al. (2020;https://doi.org/10.5334/dsj-2020-005), which was published under a CC BY license.
Statement examples from Hrynaszkiewicz et al. (2020)
E The datasets generated during and/or analyzed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS].
E The datasets generated during and/or analyzed during the current study are not publicly available due to [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
E The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
E Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
E All data generated or analyzed during this study are included in this published article [and its supplementary information files].
E The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are available, however, from the authors upon reasonable request and with permission of [third party name].
Authors must disclose the source of publicly available data and materials, such as public repositories or commercial manufacturers, by including accession numbers or company details in their manuscript, as appropriate.
Authors are encouraged to make their own data and materials available by linking from their manuscript to J-STAGE Data (see below), a data repository developed and managed by the Japan Science and Technology Agency (JST), or other community-recognized public database or digital repositories.
All data sets must be made available in full to the editors and reviewers during the peer review process, and should be made publicly available by the date of publication. Authors commit to preserving their data sets for at least ten years from the date of publication in the journal.
The journal encourages authors to grant reasonable requests from colleagues to share any data, materials and experimental protocols described in their manuscript.
The Journal of UOEH recommends that the data underlying the manuscript be made available on J-STAGE Data, a data repository operated by the Japan Science and Technology Agency. Authors who opt to make data available on J-STAGE Data should contact the Editorial Office for further instructions. If authors wish to publish data from J-STAGE Data, they must submit the data and its metadata to the editorial board for peer review. The copyright of the data published by J-STAGE Data is held by the UOEH Association of Health Science. Data is made available under the Creative Commons the CC-BY-NC-ND 4.0 International license.
The journal is committed to maintaining the highest ethical standards. Experimental investigations of human subjects should conform to the Code of Ethics of the World Medical Association; that is, the Declaration of Helsinki and its revisions. Any guidelines approved by the authorsf institutions must also be followed. Details that might disclose the identity of the subjects in the study should be omitted.
Where relevant, the authors must include a statement in the eEthics approval and consent to participatef section of their manuscript that describes the procedures for obtaining informed consent from participants regarding participation in the research.
Authors must also include a ePatient consent for publicationf section in their manuscript that details the consents obtained for the publication of the research that involves human subjects.
In the case of animal studies, authors are obliged to follow internationally accepted principles concerning the care and use of laboratory animals (c.f. National Research Council. 2001. Guide for the Care and Use of Laboratory Animals 8th edition. Washington, DC: The National Academies Press).
The journal adheres to the International Committee of Medical Journal Editors (ICMJE) policy on Clinical Trials Registration, which recommends that all clinical trials are registered in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. Manuscripts describing clinical trials must include the registration number of the trial and the name of the trial registry.
The journal requires authors to follow the EQUATOR Networkfs Reporting Guidelines for health research. Study types include, but are not limited to, randomized trials, observational studies, systematic reviews, case reports, qualitative research, diagnostic and prognostic studies, economic evaluations, animal pre-clinical studies, and study protocols.
As per Committee on Publication Ethics (COPE) guidance, authors must disclose and fully describe any use of generative or non-generative artificial intelligence (AI) tools (also known as large language models or LLMs) in the Materials and Methods. This includes, but is not limited to, using AI tools to collect or analyze data, produce or amend images or graphics used in the manuscript, or write all or part of the manuscript. Authors must describe which tools they used and how the tools were used. In general, the use of generative AI tools is allowed only where that use is an integral part of the research design or methods. Other use will be reviewed on a case-by-case basis. In all cases, authors remain responsible for all the content of their submitted manuscript.
Authors should be aware that there are ongoing concerns about the copyright status of any AI-generated content. Authors must adhere to the instructions in the eReproducing copyrighted materialf section of this document and comply with relevant statutory and other copyright laws.
It is acceptable to use non-generative AI tools to improve the readability of a manuscript, such as through spelling and grammar checking.
Reviewers and editors must not upload unpublished manuscripts to any AI tool or service. Doing so would breach privacy and confidentiality provisions, as described elsewhere in this document. There are also potential copyright issues if unpublished material is uploaded to a third-party service.
A conflict of interest exists when there are actual, perceived or potential circumstances that could influence an authorfs ability to conduct or report research impartially. Potential conflicts include (but are not limited to) competing commercial or financial interests, commercial affiliations, consulting roles, or ownership of stock or equity. In the interests of transparency, the journal requires all authors to declare any competing or conflicts of interest in relation to their submitted manuscript. The style and format required for the declaration are listed in the eConflict of interest (COI) statementf section of this document.
Authors should list all funding sources for their work in the Funding section of their manuscript.
The journal maintains the confidentiality of all unpublished manuscripts. By submitting their manuscript to the journal, the authors warrant that they will keep all correspondence about their manuscript (from the Editorial Office, editors and reviewers) strictly confidential.
Self-archiving, also known as Green Open Access, enables authors to deposit a copy of their manuscript in an online repository. The journal encourages authors of original research manuscripts to upload their article to an institutional or public repository immediately after publication in the journal.
J-STAGE preserves its full digital library, including the journal, with Portico in a dark archive (see https://www.portico.org/publishers/jstage/). In the event that the material becomes unavailable at J-STAGE, it will be released and made available by Portico.
The journal does not allow advertising in its article pages or on the journalfs website.
The journal uses single-anonymized peer review. When a manuscript is submitted to the journal, the style and format are checked by the Editorial Office. Those compliant are then assigned to the Editor-in-Chief or an Editor, who performs the initial screening. Manuscripts that do not fit the journalfs scope or are not deemed suitable for publication are returned to the corresponding author without review. The remaining manuscripts are assigned to an Editor who finds at least two reviewers for Original and Review articles, and at least one reviewer for other types, to assess each manuscript. Reviewers are selected based on their expertise, reputation, and previous experience as peer reviewers.
Upon receipt of the reviewersf reports, the Editor makes the first decision on the manuscript. If the decision is to request revision of the manuscript, authors have 3 months to resubmit their revised manuscript. Revised manuscripts submitted after this deadline may be treated as new submissions. The Editor may send revised manuscripts to peer reviewers for their feedback or may use his or her own judgment to assess how closely the authors have followed the Editorfs and the reviewersf comments on the original manuscript.
The Editor then makes a recommendation to the Editor-in-Chief on the manuscriptfs suitability for publication. The Editor-in-Chief is responsible for making the final decision on each manuscript.
The members of the Editorial Board act in advisory roles, making, for example, suggestions to improve the journal. In cases where the Editor-in-Chief is an author on a manuscript submitted to the journal, a member of the Editorial Board is responsible for making the final decision on the manuscriptfs suitability for publication in the journal.
Reviewers are selected based on their expertise in the field, reputation, recommendation by others, and/or previous experience as peer reviewers for the journal.
Reviewers are asked to submit their first review within 2 weeks of accepting the invitation to review. Reviewers who anticipate any delays should inform the Editorial Office as soon as possible.
When submitting a manuscript to the journal, authors may suggest reviewers that they would like to be included in or excluded from the peer review process. The Editor may consider these suggestions but is under no obligation to follow them. The selection, invitation and assignment of peer reviewers is at the sole discretion of the Editor.
It is the journalfs policy to transmit reviewersf comments to the authors in their original form. However, the journal reserves the right to edit reviewersf comments, without consulting the reviewers, if they contain offensive or derogatory language, confidential information, or recommendations for publication.
If a manuscript satisfies the journalfs requirements and represents a significant contribution to the published literature, the Editor may recommend acceptance for publication in the journal.
Articles in the journal must be:
* within the subject area of the journalfs scope
* novel and original
* descriptions of technically rigorous research
* of high interest to the journalfs audience
* important additions to the field
If a manuscript does not meet the journalfs requirements for acceptance or revision, the Editor may recommend rejection.
The UOEH Association of Health Science has granted the journalfs Editorial Board complete and sole responsibility for all editorial decisions. The UOEH Association of Health Science will not become involved in editorial decisions, except in cases of a fundamental breakdown of process.
Editorial decisions are based only on a manuscriptfs scientific merit and are kept completely separate from the journalfs other interests. The authorsf ability to pay any publication charges has no bearing on whether a manuscript is accepted for publication in the journal.
Authors who believe that an editorial decision has been made in error may lodge an appeal with the Editorial Office. Appeals are only considered if the authors provide detailed evidence of a misunderstanding or mistake by a reviewer or editor. Appeals are considered carefully by the Editor-in-Chief, whose decision is final. The guidelines of COPE are followed where and when relevant.
The journal maintains the confidentiality of all unpublished manuscripts. Editors and reviewers will not:
1. disclose a reviewerfs identity unless the reviewer makes a reasonable request for such disclosure
2. discuss the manuscript or its contents with anyone not directly involved with the manuscript or its peer review
3. use any data or information from the manuscript in their own work or publications
4. use information obtained from the peer review process to provide an advantage to themselves or anyone else, or to disadvantage any individual or organization
5. share or upload the content of the manuscript with any AI tool or public platform
In addition, reviewers will not reveal their identity to any of the authors of the manuscript or involve anyone else in the review (for example, a postdoctoral or PhD student) without first receiving permission from the Editor.
A conflict of interest exists when there are actual, perceived, or potential circumstances that could influence an editor or reviewerfs ability to act impartially when assessing a manuscript. Such circumstances might include having a personal or professional relationship with an author, working on the same topic or in direct competition with an author, having a financial stake in the work or its publication, or having seen previous versions of the manuscript.
Reviewers and members of the journalfs Editorial Board undertake to declare any conflicts of interest when handling manuscripts. An editor or reviewer who declares a conflict of interest is unassigned from the manuscript in question and is replaced by a new editor or reviewer.
Editors try to avoid conflicts of interest when inviting reviewers, but it is not always possible to identify potential bias.
The journal recognizes the importance of maintaining the integrity of published literature.
A published article that contains an error may be corrected through the publication of an Erratum. Errata describe errors that significantly affect the scientific integrity of a publication, the reputation of the authors, or the journal itself. Authors who wish to correct a published article should contact the editor who handled their manuscript or the Editorial Office with full details of the error(s) and their requested changes. In cases where co-authors disagree over a correction, the Editor-in-Chief may consult the Editorial Board or external peer reviewers for advice. If a Correction is published, any dissenting authors will be noted in the text.
A published article that contains invalid or unreliable results or conclusions, has been published elsewhere, or has infringed codes of conduct (covering research or publication ethics) may be retracted. Individuals who believe that a published article should be retracted are encouraged to contact the journalfs Editorial Office with full details of their concerns. The Editor-in-Chief will investigate further and contact the authors of the published article for their response. In cases where co-authors disagree over a retraction, the Editor-in-Chief may consult the Editorial Board or external peer reviewers for advice. If a Retraction is published, any dissenting authors will be noted in the text.
The decision to publish Errata or Retractions is made at the sole discretion of the Editor-in-Chief.
Any member of the journalfs Editorial Board, including the Editor-in-Chief, who is an author on a submitted manuscript is excluded from the peer review process. Within the journalfs online manuscript submission and tracking system, they will be able to see their manuscript as an author but not as an editor, thereby maintaining the confidentiality of peer review.
A manuscript authored by an editor of the journal is subject to the same high standards of peer review and editorial decision making as any manuscript considered by the journal.
The journal will respond to allegations of ethical breaches by following its own policies and, where possible, the guidelines of COPE.
On 1 March, 2024, the journal will introduce open licensing for its articles. Unmodified material published from this date can be used or reused without prior permission in ways defined by the Creative Commons license detailed below. End users must continue to obtain permission from the journal for the reuse of modified material published from the changeover date.
Material published before 1 March, 2024 will be freely available and able to be re-used under statutory copyright provisions. Permission for the re-use of material published before 1 March, 2024 must be sought from the journal by contacting the Editorial Office (see the eContactf section of this document for details).
Authors are required to assign all copyrights in the work to the UOEH Association of Health Science via the copyright transfer agreement (PDF format; DOC format). From 1 March, 2024, articles are published under the CC-BY-NC-ND (Attribution-NonCommercial-NoDerivatives) 4.0 International license. The CC-BY-NC-ND 4.0 license allows users to copy and share unmodified articles, as long as appropriate credit is given. Permission to use articles for commercial purposes can be sought by contacting the Editorial Office.
Some funding bodies require articles funded by them to be published under a specific Creative Commons license. Before submitting your work to the journal, check with the relevant funding bodies to ensure that you comply with any mandates.
There are no publication charges and no submission fee.
All manuscripts must be submitted via the journalfs online submission system, ScholarOne: https://mc.manuscriptcentral.com/JUOEH. The original or revised manuscript text may be uploaded as a PDF or Microsoft Word file, but a Word file is required for the final manuscript text. Figures may be submitted separately in several other formats.
If you encounter any problems with online submission, please contact the Editorial Office: j-uoeh@mbox.med.uoeh-u.ac.jp.
Manuscripts should be prepared in Microsoft Word (.doc, .docx; not write-protected) using double spacing throughout (including tables, legends, footnotes, references, etc.), A4 format, portrait layout, and page margins of 2.5 cm. Each page should fit approximately 20 lines, each with around 80 typewriting strokes, including spaces. Thus, two such consecutive pages will become equivalent to one journal-typeset page.
Manuscripts can be submitted in either US English or Japanese. English manuscripts should be written in clear, grammatically correct English. If a manuscript is not clear due to poor English, it may be rejected without undergoing peer review.
Submissions must include a cover letter including the manuscript title and the corresponding authorfs contact details. Authors should summarize the aims and outcomes of their work and how and why the work is appropriate for publication. Details of any relevant consent and/or ethics approvals and other such items must be included in the cover letter.
Manuscripts should be presented in the following order: title; author name(s); affiliation(s) and address(es); Abstract (not exceeding 250 words); keywords (no more than five phrases); main text; acknowledgments (if applicable); author declaration sections; references; tables and/or figures.
The title should describe the content of the article briefly but clearly and is important for search purposes by third-party services. Do not use the same main title with numbered minor titles, even for a series of papers by the same authors. Do not use abbreviations in the title, except those used generally in related fields.
Provide the full names, with initials, of the author(s).
Provide full names and addresses of institutions (including laboratory, department, institute and/or university, city, state and country). When authors belong to different institutions, their respective addresses should be indicated by superscript numbers. When authors have new addresses, they should be given in a footnote and should be indicated by superscript symbols (such as * and **).
A maximum of five keywords or key phrases should be provided.
The running title should not exceed 50 characters, including spaces.
Footnotes, if any, should be typed in a separate sheet (the second page of the manuscript). Abbreviations should also be listed on this page.
SI or SI-derived units should be used. More information on SI units is available at the Bureau International des Poids et Mesures (BIPM) website.
The Abstract should be unstructured but clearly express the basic content of the paper in a single paragraph and should include the problem addressed, experimental approach, main results and findings, and conclusions. Abstracts must not exceed 250 words for all article types. Avoid using specific abbreviations. If it is essential to refer to a previous publication, omit the article title (e.g. Maekawa, S., Endo, S., and Sakai, H. (2015). Sci. Journal., 14: 10-15).
The Introduction should provide sufficient background information to allow the reader to understand the purpose of the investigation and its relationship with other research in related fields, although it should not include an extensive review of the literature.
The description of the methods should be brief, but it must include sufficient details to allow the experiments to be repeated. The sources of unusual chemicals, animals, microbial strains or equipment should be described, and the location (city, country) of the company should be provided in parentheses. If hazardous materials or dangerous procedures are used in the experiments and the precautions related to their handling are not widely recognized, it is recommended that the authors provide the necessary details.
This section includes the results of the experiments. The Results and Discussion sections may be combined if this helps readers to understand and evaluate the study. Tables and figures, including photographs, can be used to present the experimental results (see below). Excessive explanations of the data presented in tables and figures should be avoided.
The Discussion should be concise and should deal with the interpretation of the results. Novel models or hypotheses may be proposed in this section only if they are suggested by the results obtained in the experiments. Do not repeat the description of the experimental results in this section.
Except for standard abbreviations or symbols, such as mg/ml or NaCl, nonstandard abbreviations must be accompanied by the full spellings when they first appear in the text. The metric system must be used in quantitative expressions.
This section should be brief and acknowledge those that have assisted in the work or preparation of the manuscript, but who do not qualify for authorship, as defined in the eAuthorshipf section of this document.
Authors should list all funding sources for their work in a section of the manuscript entitled eFundingf. Where possible and for each grant, the following information should be included: the receiving institution, the funding agency, the grant number, and the location (city and country) of the funding agency.
Authors must disclose any financial or personal relationships that may pose a conflict of interest. All disclosures should be included in the manuscript by the authors under the heading gConflict of Interest (COI)h, which should be placed in a separate section before the reference list. If no conflict of interest is declared, then gNoneh should be written in this section.
Authors are encouraged to include a Data Availability Statement in manuscripts that report results from research data. Following Hrynaszkiewicz et al. (2020, http://doi.org/10.5334/dsj-2020-005), statements should include information on where the manuscriptfs data can be found and hyperlinks (where applicable) to it. If research data are not publicly available, this should be stated in this section along with any conditions for accessing the data.
Authors are required to include a statement that specifies the contribution of each author, following CRediT (Contributor Roles Taxonomy). Authors should examine the CRediT website and ascribe one or more of the 14 CRediT categories to each author. For example (use the actual author names in your manuscript):
Conceptualization: Author 1.
Funding acquisition: Author 1.
Investigation: Author 1, Author 2.
Supervision: Author 1.
Visualization: Author 3.
Writing-original draft: Author 1, Author 2, Author 3.
Writing-review & editing: Author 1, Author 2.
For any studies involving human or animal subjects, authors are required to declare that they obtained and were compliant with relevant ethics approvals. If such ethics approval is not relevant or applicable, authors should include the statement gNot applicableh under this section heading in their manuscript.
For any studies involving human subjects, authors are required to declare that they obtained informed consent from patients for the publication of information relating to them. If such consent is not relevant or applicable, authors should include the statement gNot applicableh under this section heading in their manuscript.
References should be cited in the text using Arabic numerals arranged in order of citation and placed in square brackets, e.g. [7] or [11-13, 17], and listed at the end of the paper in consecutive numerical order. All listed references must be cited in the text or tables. Although unpublished data and personal communication should not be listed as references, the citation gin pressh is acceptable. The following styles are to be used:
Journal Articles
Surname Initials (Year): Full title. Journal VOLUME (issue): first page-last page, PMID
Papers in Books
Surname Initials (Year): Title of the paper. In: Title of the Book. (Editor surname(s) Initials, ed(s)). Publisher, Place, pp page-page
Books
Surname Initials (Year): Full Title, Edition. Publisher, Place, pp page-page or p page cited or total pages pp
Websites
Publisher (Year): Title of the page. URL (accessed month date, year)
For multiple authors, the symbol g&h should be inserted between the last two authors, instead of gandh, regardless of the language used. For up to six authors, list the names of all authors; for seven or more authors, list the first 3 authors followed by get alh.
For works written in a language other than English, indicate that at the end of the reference; e.g. g(in Japanese)h.
Tables should appear on separate pages, numbered with Arabic numerals, and accompanied by a caption at the top and explanatory matter placed in footnotes below the bottom line. Neither vertical nor oblique lines should be used. The author should submit electrically formatted original drawings (EPS) or well-contrasted images (TIFF or JPEG) of high quality (resolution: 600 to 1200 dpi for line drawings and at least 300 dpi for images) suitable for reproduction. Each figure should be on a separate page and accompanied by succinct legends. Every table and figure must be referred to in the text.
Upon manuscript acceptance, the Editorial Office will ask the corresponding author for relevant information to enable the paperfs production.
Manuscripts that are accepted for publication are copyedited and typeset by the journalfs production team before publication. The journal is published four times per year on J-STAGE and on the journalfs website. All communication regarding accepted manuscripts is with the corresponding author.
Page proofs are emailed as PDFs to the corresponding author, who should carefully check and return them within 3 days. Only essential corrections to typesetting errors or omissions are accepted; excessive changes are not permitted at the proofing stage.
Any editorial correspondence or questions should be addressed to:
Editor-in-Chief
Prof. Masanori HISAOKA
c/-Editorial Office of the Journal of UOEH
University of Occupational and Environmental Health, Japan
Yahatanishi-ku, Kitakyushu 807-8555, Japan
Telephone & Fax: +81-93-691-7291
E-mail: j-uoeh@mbox.med.uoeh-u.ac.jp
(Copyright 2024 University of Occupational and Environmental Health, Japan.) Updated: 1 April 2024
Please select an issue.
